Xin Tan Selected Research

Neoplasms (Cancer)

1/2022	Effects of high-dose all-trans retinoic acid on longitudinal bone growth of young rats.
7/2021	Overexpression of ING3 is associated with attenuation of migration and invasion in breast cancer.
1/2021	Evaluation of the body mass index in breast cancer prognosis in a cohort of small-stature overweight patients: multi-center study in China.
12/2020	Sclerosing stromal tumor of the ovary with masculinization, Meig's syndrome and CA125 elevation in an adolescent girl: A case report.
7/2017	Synthetic lethal short hairpin RNA screening reveals that ring finger protein 183 confers resistance to trametinib in colorectal cancer cells.
1/2017	Minicircle-oriP-miR-31 as a Novel EBNA1-Specific miRNA Therapy Approach for Nasopharyngeal Carcinoma.
8/2015	Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity.
3/2014	Transgene IL-6 enhances DC-stimulated CTL responses by counteracting CD4+25+Foxp3+ regulatory T cell suppression via IL-6-induced Foxp3 downregulation.
12/2010	Pilocytic astrocytomas have telomere-associated promyelocytic leukemia bodies without alternatively lengthened telomeres.
6/2007	[Effects of adenoviral-mediated mda-7/IL-24 gene infection on the growth and drug-resistance of drug-resistant].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xin Tan Research Topics

Disease

10	Infections 07/2022 - 04/2007
10	Neoplasms (Cancer) 01/2022 - 06/2007
6	Inflammation (Inflammations) 12/2021 - 01/2017
5	Ovarian Neoplasms (Ovarian Cancer) 10/2010 - 01/2007
4	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2017
3	COVID-19 01/2021 - 04/2020
3	Nasopharyngeal Carcinoma 03/2019 - 01/2017
3	Alzheimer Disease (Alzheimer's Disease) 10/2018 - 05/2017
3	Melanoma (Melanoma, Malignant) 01/2018 - 07/2017
3	Carcinogenesis 10/2017 - 01/2017
2	Pneumonia (Pneumonitis) 05/2022 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2021
2	Milk Hypersensitivity (Milk Allergy) 01/2022 - 10/2021
2	Heart Failure 01/2022 - 11/2021
2	Atherosclerosis 01/2022 - 12/2016
2	Essential Hypertension 11/2021 - 01/2020
2	Breast Neoplasms (Breast Cancer) 07/2021 - 10/2020
2	Stomach Neoplasms (Stomach Cancer) 05/2021 - 03/2010
2	Hypertension (High Blood Pressure) 01/2021 - 01/2020
2	Metabolic Bone Diseases (Osteopenia) 10/2020 - 10/2015
2	Cerebral Hemorrhage 06/2020 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 09/2017 - 07/2017
2	Experimental Melanoma 07/2015 - 03/2014
2	Carcinoma (Carcinomatosis) 02/2012 - 10/2010
2	Astrocytoma (Pilocytic Astrocytoma) 02/2012 - 12/2010
1	Hyperbilirubinemia 08/2022
1	Food Hypersensitivity (Food Allergy) 07/2022
1	Bacterial Infections (Bacterial Infection) 05/2022
1	Fistula 05/2022
1	Empyema 05/2022
1	Hypertrophy 03/2022
1	Coma (Comas) 02/2022
1	Disease Progression 01/2022
1	Developmental Bone Diseases (Bone Dysplasia) 01/2022
1	Diabetes Complications 01/2022
1	Atrial Fibrillation 01/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2022
1	Hepatitis B 01/2022
1	Urinary Retention 01/2022
1	Atrial Remodeling 01/2022
1	Starvation 12/2021
1	Stroke (Strokes) 11/2021
1	Acute Coronary Syndrome 11/2021
1	Coronary Disease (Coronary Heart Disease) 11/2021
1	Chronic Renal Insufficiency 08/2021

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 01/2022 - 01/2007
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2007
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
3	Immunoglobulin E (IgE)IBA 07/2022 - 10/2021
3	Biological ProductsIBA 02/2022 - 09/2017
3	LipidsIBA 01/2022 - 01/2017
3	Long Noncoding RNAIBA 07/2021 - 09/2017
3	Phenobarbital (Luminal)FDA Link 07/2021 - 10/2020
2	AntioxidantsIBA 08/2022 - 01/2021
2	Adenosine Monophosphate (AMP)IBA 07/2022 - 03/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 01/2017
2	Carbapenems (Carbapenem Antibiotics)IBA 05/2022 - 01/2021
2	AldosteroneIBA 01/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2014
2	Lactic Acid (Lactate)FDA LinkGeneric 12/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 07/2021 - 09/2017
2	MicroRNAs (MicroRNA)IBA 07/2021 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 01/2021
2	recombinant interferon alpha 2b-like proteinIBA 01/2021 - 10/2020
2	LuteolinIBA 06/2020 - 01/2019
2	CytokinesIBA 01/2019 - 01/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2018 - 01/2018
2	XenonIBA 01/2018 - 05/2017
2	VaccinesIBA 07/2015 - 03/2014
2	DNA (Deoxyribonucleic Acid)IBA 02/2012 - 12/2010
2	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2012 - 12/2010
1	7,3'-dihydroxy-4'-methoxyisoflavoneIBA 08/2022
1	Neuroprotective AgentsIBA 08/2022
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 03/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2022
1	QuercetinIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	RetinoidsIBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022
1	Staphylococcal Protein A (Protein A)IBA 12/2021
1	Colistin (Coly-Mycin)FDA Link 12/2021
1	Polymyxin B (Aerosporin)FDA LinkGeneric 12/2021
1	omega-Chloroacetophenone (Mace)IBA 11/2021
1	CeramidesIBA 11/2021
1	Immunoglobulin G (IgG)IBA 10/2021
1	AllergensIBA 10/2021
1	Serine (L-Serine)FDA Link 07/2021
1	Competitive Endogenous RNAIBA 07/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 07/2021
1	Threonine (L-Threonine)FDA Link 07/2021

Therapy/Procedure

6	Therapeutics 11/2019 - 08/2015
2	Phage Therapy 05/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2022 - 10/2020
2	Radiotherapy 03/2019 - 11/2017
2	Immunotherapy 08/2015 - 03/2014
1	Pneumonectomy (Lung Volume Reduction) 05/2022
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 01/2022
1	Catheters 01/2022
1	Patient Readmission 01/2022
1	Medication Reconciliation 08/2021